Microdosing Psilocybin for Beginners in 5 Easy Steps
Journal. Measure. Schedule. Listen. Flourish. This increasingly popular practice only pays off with careful intention and execution.
James Hallifax is an entrepreneur who co-founded The Psychedelic Investor, a media company focused on investing in psychedelic medicines which treat mental health conditions. Together with his business partner, they have grown their YouTube Channel to be the largest Channel dedicated to Investing in Psychedelics. Through their partnership with Psychedelic Spotlight, James aims to help educate retail investors on the potential for substances like LSD, MDMA and Magic Mushrooms to heal, and for early investors who make the right choices to make a lot of money. Rather than focus on day to day stock movements, James follows the underlying science of the industry, to help people understand which companies are the most likely to succeed long term.
Journal. Measure. Schedule. Listen. Flourish. This increasingly popular practice only pays off with careful intention and execution.
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end of life care
India is known as the home of the visionary brew Soma, Goa Trance, and Bhang Lassies, but what is the legal status of psychedelics in India?
High doses of cannabis can cause hallucinations and otherworldly experiences, but is marijuana a psychedelic? Here are some facts
Psychedelic decriminalization has long been the goal of many activists, but it is a long way from true legalization. What's the difference?
A lawsuit filed by the non-profit advocacy group TheraPsil is leading the effort to make psilocybin-assisted therapy available to Canadian patients with a doctor's recommendation
The DEA backs off announces they are withdrawing a proposed rule to ban the psychedelic drugs DOI and DOC, at least for now
The Canadian Minister of Mental Health and Addictions met with members of the Oregon psilocybin program, a surprise move which may signify easing restrictions on psychedelics
The DEA moves to ban two obscure psychedelic drugs, DOI and DOC, amidst ongoing calls to ease restrictions on psychedelic medicines
The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.